In the BioHarmony Drug Report Database

"Preview" Icon

Cholecalciferol

Fosamax Plus D (cholecalciferol) is a small molecule pharmaceutical. Cholecalciferol was first approved as Fosamax Plus D on 2005-04-07. It is used to treat cardiovascular diseases, chronic kidney failure, crohn disease, familial hypophosphatemic rickets, and hypoparathyroidism amongst others in the USA.

 

Trade Name

 

Fosamax Plus D
 

Common Name

 

cholecalciferol
 

ChEMBL ID

 

CHEMBL1042
 

Indication

 

cardiovascular diseases, chronic kidney failure, crohn disease, familial hypophosphatemic rickets, hypoparathyroidism, lung neoplasms, osteoporosis, psoriasis, skin neoplasms
 

Drug Class

 

Vitamin D analogues

Image (chem structure or protein)

Cholecalciferol structure rendering